[Federal Register Volume 80, Number 16 (Monday, January 26, 2015)]
[Notices]
[Page 3988]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-01287]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: S & B Pharma, 
Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: S & B Pharma, Inc. applied to be registered as a manufacturer 
of certain basic classes of controlled substances. The DEA grants S & B 
Pharma, Inc. registration as a manufacturer of those controlled 
substances.

SUPPLEMENTARY INFORMATION: By notice dated July 1, 2014, and published 
in the Federal Register on July 8, 2014, 79 FR 38564, S & B Pharma, 
Inc., DBA Norac Pharma, 405 South Motor Avenue, Azusa, California 
91702-3232 applied to be registered as a manufacturer of certain basic 
classes of controlled substances. No comments or objections were 
submitted to this notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823(a) and determined that the registration of S & 
B Pharma, Inc. to manufacture the basic classes of controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed:

------------------------------------------------------------------------
            Controlled Substance                       Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)...........  I
Tetrahydrocannabinols (7370)...............  I
Methamphetamine (1105).....................  II
Pentobarbital (2270).......................  II
Nabilone (7379)............................  II
4-Anilino-N-phenethyl-4-piperidine (ANPP)    II
 (8333).
Tapentadol (9780)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for use in product development and for commercial sales to its 
customers.

    Dated: January 9, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-01287 Filed 1-23-15; 8:45 am]
BILLING CODE P